Cancer is a community-wide problem that demands collaboration for progress to be made. NOA believes that change comes through collaboration and it works across a number of groups that support and underpin it’s goals - NOA calls those groups ‘pillars’ and they’re categorised by the shared experience of the members of the group.
Four Pillars
NOA’s four pillars are patients, patient groups, clinicians and the pharmaceutical industry, each of which bring an important voice and experience to our work:
Cancer patients & carers
are the experts in the cancer experience as they deal with the realities of cancer every day. Their voice is critical to comprehensive solutions for the future.
Patient groups
offer a broader perspective, representing the diverse needs of their communities and how policies and services impact them.
Clinicians
have the passion to change lives, with front-line perspectives on system failures as well as the possibilities we need to make a reality.
Pharmaceutical companies
are investing in research and delivering on the innovation that gives hope to people living with cancer. Everyone wants Australians to have access to the latest treatments at an affordable price, so industry input is key.
Pillar Heads report to the Steering Committee.
NOA’s work is directed by a Steering Committee, co-chaired by Professor John Zalcberg, who brings a wealth of research experience, alongside Rare Cancers Australia CEO Richard Vines while NOA’s four pillars are patients, patient groups, clinicians and the pharmaceutical industry.
Meet the Steering Committee
NOA will work with a broad range of stakeholders across various disease areas, as well as the Oncology Industry Taskforce (OIT) of Medicines Australia, the Medical Oncology Group of Australian Incorporated (MOGA), and the Haematology Society of Australia & New Zealand (HSANZ).